Cook, Angiotech restructure licensing deal

Interventional technology developer Cook has restructured its license agreement for drug-eluting medical devices with Angiotech, accommodating Cook's decision to focus its product developments efforts on peripheral vascular and gastrointestinal drug-eluting medical devices.

Under the terms of the agreement, Angiotech will pay Cook $25 million and grant the company the right to use distributors for licensed products. In exchange, Bloomington, IN-based Cook has agreed to a termination of its rights under the agreement in the coronary vascular field of use. Angiotech has also granted Cook a multiyear extension in the peripheral vascular and gastrointestinal areas.

By staff writers
September 24, 2004

Related Reading

Cook to begin U.S. trial for drug-eluting, non-coronary stent, July 28, 2004

Cook gets clearance for new stent, January 20, 2004

Cook to begin testing endovascular TAA graft, December 11, 2003

Cook signs three-year deal with MedAssets, August 19, 2003

Cook taps McIntosh for medical officer role, April 28, 2003

Copyright © 2004

Page 1 of 180
Next Page